BOSTON – Extensive surgery beyond lobectomy offers no survival advantage for small papillary thyroid cancers, according to a large database analysis.
Total thyroidectomy was not associated with an...
LAS VEGAS – Nondiabetic patients with nonalcoholic fatty liver disease already have insulin perturbations putting them on track for a variety of more serious health conditions, new data show.
In a...
LAS VEGAS – Analysis of data from a company that provides therapy for low testosterone showed that the treatment was not associated with a higher risk of myocardial infarction and stroke in men, and...
LAS VEGAS – The antidiabetic drug liraglutide (Victoza) promotes weight loss in overweight and obese individuals who do not have diabetes, according to results from a randomized trial reported on May...
LAS VEGAS —Your patient’s body mass index indicates obesity. Now, what’s the course of action?
The American Association of Clinical Endocrinologists and the American College of Endocrinology are...
LAS VEGAS – Testosterone improves insulin sensitivity and insulin signaling in diabetic men who are deficient in this hormone, finds a randomized trial reported at the annual meeting of the American...
LAS VEGAS – Evolocumab, an investigational antibody that inhibits PCSK9, reduces levels of low-density lipoprotein cholesterol in hypercholesterolemic patients who have dysglycemia or metabolic...
LAS VEGAS – In the opinion of Dr. David Cherney, it’s not uncommon for physicians to feel grim about the limited efficacy of available agents to treat chronic kidney disease in patients with type 1...
LAS VEGAS – Hispanic adults have high prevalences of diabetes and related disorders overall, the largest ongoing U.S. health study of this population showed, but there are noteworthy differences by...
